The Role of Mediven® ProDetect® Test Kits in Screening Omicron and Arcturus XBB 1.16 Variants
The COVID-19 pandemic has been raging for over two years now and it has continued to evolve over time. The virus has undergone numerous mutations, leading to the emergence of different variants.
Some of the variants that have been making headlines recently are the Omicron and Arcturus XBB 1.16 variants.
The Omicron variant was first detected in South Africa in November 2021 and has since spread to several countries around the world. According to the World Health Organization (WHO), the Omicron variant has a large number of mutations, which makes it highly transmissible. There is still much to learn about this variant, but initial reports suggest that it may be more resistant to some of the current COVID-19 vaccines.
The Arcturus XBB 1.16 variant, on the other hand, was first identified in India in late January 2023 and has spread to 29 other countries. This variant is also highly transmissible and is of concern to health experts because it has a mutation in the spike protein of the virus, which could make it more resistant to current vaccines.
To combat the spread of COVID-19 and its variants, testing is critical. The Mediven® ProDetect® nasal/saliva test kits are highly effective in screening for all variants of COVID-19, including the Omicron and Arcturus XBB 1.16 variants. These kits have been rigorously tested and have achieved a 100% accuracy score in a well-regarded international third-party External Quality Assessment Programme (EQAP) conducted by the European Society for EXTERNAL QUALITY ASSESSMENT (EsFEQA). This recognition is a testament to the quality and accuracy of the Mediven® ProDetect® kits, giving customers even greater peace of mind when using these kits.
In conclusion, the emergence of new COVID-19 variants such as Omicron and Arcturus XBB 1.16 has underscored the importance of accurate and reliable testing solutions. The Mediven® ProDetect® nasal/saliva test kits provide a comprehensive screening solution for all variants of the virus, including the highly transmissible and potentially vaccine-resistant Omicron and Arcturus XBB 1.16 variants. By utilizing MDA approved and Malaysia-made Mediven® ProDetect® test kits, we can proactively detect, isolate, and manage the spread of COVID-19 and its variants, preventing minor outbreaks from turning into major ones.
